4D MOLECULAR THERAPEUTICS IN (FDMT) — institutional ownership

168 funds reported holding 4D MOLECULAR THERAPEUTICS IN in their latest 13F filings, worth $851M in total (CUSIP 35104E100).

Largest holders

1. Jupiter Topco LLC — $76.5M
2. RA CAPITAL MANAGEMENT, L.P. — $67.2M
3. BlackRock, Inc. (BLK) — $60.5M
4. GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $56.6M
5. JANUS HENDERSON GROUP PLC (JHG) — $48.9M
6. Novo Holdings A/S — $43.2M
7. STATE STREET CORP (STT, STT-PG) — $38.7M
8. BVF INC/IL — $38.3M
9. T. Rowe Price Investment Management, Inc. — $33.4M
10. ADAGE CAPITAL PARTNERS GP, L.L.C. — $29.9M

Famous investors holding it

• Ken Griffin portfolio (Citadel Advisors)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Two Sigma portfolio (Two Sigma Investments)
• D. E. Shaw portfolio (D. E. Shaw & Co.)

Insider buying and selling at 4D MOLECULAR THERAPEUTICS IN

Who owns the most FDMT stock?

The largest institutional holders in the latest 13F filings are Jupiter Topco LLC ($76.5M), RA CAPITAL MANAGEMENT, L.P. ($67.2M), BlackRock, Inc. (BLK) ($60.5M).

How many funds own FDMT?

168 funds reported holding it, worth $851M in total.